The Nobel Prize in Physiology or Medicine was awarded today to Victor Ambros and Gary Ruvkun for their pivotal discovery of microRNA—tiny genetic elements that regulate gene activity at the cellular level
The Nobel Prize in Physiology or Medicine has been awarded to scientists Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNA, tiny genetic elements that regulate gene activity at the cellular level. This pivotal finding holds significant promise for developing innovative cancer therapies.
The announcement, made on Monday, marks the start of the 2024 Nobel Prize season, which celebrates extraordinary achievements across science, economics, literature, and peace. The Nobel Assembly at the Karolinska Institute described the discovery as "fundamentally important" for understanding how organisms develop and function. The Medicine or Physiology prize is the first in a series of Nobel announcements, running from October 7 to 14.
Ambros and Ruvkun first published their findings in 1993, unveiling a new layer of gene regulation that has since proven crucial and evolutionarily conserved. Dr. Claire Fletcher, a molecular oncology expert at Imperial College London, praised the discovery, stating that microRNA has transformed the way scientists approach treating diseases such as cancer by enabling precise regulation of gene function at the cellular level.
Each Nobel Prize comes with an award of 11 million Swedish crowns (approximately $1.1 million), which can be shared by up to three recipients. The next Nobel announcement, for Physics, is set for Tuesday, followed by Chemistry on Wednesday, Literature on Thursday, and the Nobel Peace Prize on Friday.
The global oil market may be tighter than headline supply-demand figures suggest, the International Energy Agency (IEA) said Friday, citing rising ref...
European shares dropped on Friday after President Donald Trump intensified tariff threats against the EU, casting doubt on trade talks and dampening i...
China’s exports are expected to have grown 5% in June as manufacturers hurried goods abroad ahead of a 12 August deadline that could see the U.S. re...
U.S. special envoy for Ukraine, Keith Kellogg, is set to arrive in Kyiv on Monday for a week-long visit, Ukrainian outlet Novyny.LIVE reported on Frid...
Kazakhstan's Ministry of Transport and Afghanistan's Ministry of Public Works have reached an agreement on the construction of a new railway line to c...
Australian researchers have pioneered a low-cost and scalable plasma-based method to produce ammonia gas directly from air, offering a green alternative to the traditional fossil fuel-dependent Haber-Bosch process.
A series of earthquakes have struck Guatemala on Tuesday afternoon, leading authorities to advise residents to evacuate from buildings as a precaution against possible aftershocks.
A deadly mass shooting early on Monday (7 July) in Philadelphia's Grays Ferry neighbourhood left three men dead and nine others wounded, including teenagers, as more than 100 shots were fired.
The 17th Summit of the Economic Cooperation Organization (ECO) was successfully held in Khankendi, Azerbaijan, highlighting the region’s revival and the deepening economic cooperation among member states.
Dozens of international and domestic flights were cancelled or delayed after Mount Lewotobi Laki Laki erupted on Monday, but Bali’s main airport remains operational.
The European Union is stepping up its health crisis preparedness by stockpiling essential medical supplies and boosting coordination among member states.
New artificial intelligence (AI) software is helping NHS hospitals in Hull reduce MRI scan times, enabling staff to scan more patients each day while improving accessibility for vulnerable groups.
France will impose its toughest outdoor smoking restrictions starting Monday, banning smoking at beaches, parks, playgrounds, and bus stops.
Scientists in Australia and the U.S. have developed an AI tool that could transform cancer care by revealing the hidden diversity of tumour cells and guiding more targeted therapies.
Singapore has launched its largest-ever study on paediatric food allergies, aiming to better understand and address the growing burden of allergic reactions among children.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment